KRT18 and adenocarcinoma: Cytokeratin 18 is primarily used as a positive marker for monolayer epithelia and is a negative marker in compound squamous epithelia, and therefore is often used in the differential diagnosis of squamous cell carcinoma and adenocarcinoma (12).